Author Archives for Lauren Rushing, BEI Intern

Merck & Co. and TEVA, Ltd. Face Legal Issues


This past week both Merck and Teva Pharmaceutical Industries, Ltd. faced legal complications concerning select drug products. Merck received a subpoena from U.S. regulators regarding marketing techniques of three drugs: Temodar, PegIntron, and Intron A in addition to dealing with problems from the Enviornmental Protection Agency. Similarly, TEVA was sued by GlaxoSmithKline and Pfizer for [...]

Pfizer Is Said to Be Pursuing Nonprescription Lipitor


[NYT] Pfizer hopes to introduce an over-the-counter version of Lipitor, the world’s best-selling drug, after it loses patent protection in November, a person close to the situation said Wednesday.
Selling a version of the drug to consumers without a prescription would allow Pfizer to retain some of the $11 billion in annual revenue that Lipitor has [...]

Insurance Coverage for Contraception Is Required


[NYT] WASHINGTON — The Obama administration issued new standards on Monday that require health insurance plans to cover all government-approved contraceptives for women, without co-payments or other charges.
The standards, which also guarantee free coverage of other preventive services for women, follow recommendations from the National Academy of Sciences and grew out of the new health [...]

Journal Editors Call for Standards in Comparative Effectiveness Research


[Science Daily] Editors of several medical research journals have issued a statement calling for rigorous standards and transparency in research that is designed to influence patient care and health policy.
Led by Dr. Harold Sox, co-chair of the 2009 US Institute of Medicine Committee on Comparative Effectiveness Research Prioritization, the statement’s author list includes editors of [...]

AIDS: No Hiding Place


[The Economist] AIDS researchers, many of whom have been meeting this week in Rome under the auspices of the International AIDS Society, are rightly pleased with the progress they have made. In particular, the use of antiretroviral drugs has not only revolutionised treatment of HIV infection, but also offers the prospect of stopping the spread [...]

Should Parents Lose Custody of Super Obese Kids?


[NYT] CHICAGO (AP) — Should parents of extremely obese children lose custody for not controlling their kids’ weight? A provocative commentary in one of the nation’s most distinguished medical journals argues yes, and its authors are joining a quiet chorus of advocates who say the government should be allowed to intervene in extreme cases.
It has [...]

CIA Organized Fake Vaccination Drive to Get Osama bin Laden’s Family DNA


[The Guardian] CIA organised fake vaccination programme in Abbottabad to try and find Osama bin Laden.
The CIA organised a fake vaccination programme in the town where it believed Osama bin Laden was hiding in an elaborate attempt to obtain DNA from the fugitive al-Qaida leader’s family, a Guardian investigation has found.
As part of extensive preparations [...]

Poison Pills


[The Economist] DRUG smugglers can expect harsh penalties nearly everywhere—if the drugs in question are heroin or cocaine. Those who smuggle counterfeit medicines, by contrast, have often faced lax enforcement and light punishment. Some governments deem drug-counterfeiting a trivial offence, little more than a common irritant. After all, whose spam filter does not groan with ads [...]

First Study of Its Kind Shows Benefits of Providing Medical Insurance to Poor


[NYT] When poor people are given medical insurance, they not only find regular doctors and see doctors more often but they also feel better, are less depressed and are better able to maintain financial stability, according to a new, large-scale study that provides the first rigorously controlled assessment of the impact of Medicaid.
While the findings may [...]

How Bright Promise in Cancer Testing Fell Apart


[NYT] When Juliet Jacobs found out she had lung cancer, she was terrified, but realized that her hope lay in getting the best treatment medicine could offer. So she got a second opinion, then a third. In February of 2010, she ended up at Duke University, where she entered a research study whose promise seemed [...]

Lauren Rushing, BEI Intern